Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NEFL anticorps

NEFL Reactivité: Humain WB, IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 1H3 unconjugated
N° du produit ABIN969548
  • Antigène Voir toutes NEFL Anticorps
    NEFL (Neurofilament, Light Polypeptide (NEFL))
    Reactivité
    • 73
    • 51
    • 39
    • 26
    • 24
    • 18
    • 4
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 58
    • 34
    • 8
    • 1
    • 1
    • 1
    Souris
    Clonalité
    • 62
    • 41
    Monoclonal
    Conjugué
    • 64
    • 9
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NEFL est non-conjugé
    Application
    • 57
    • 39
    • 32
    • 22
    • 16
    • 16
    • 14
    • 13
    • 13
    • 11
    • 11
    • 10
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Fonction
    NEFL Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of human NEFL expressed in E. Coli.
    Clone
    1H3
    Isotype
    IgG1
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Lee, Kim, Chung, Kim, Kwon, Min, Chang: "The effect of rod domain A148V mutation of neurofilament light chain on filament formation." dans: BMB reports, Vol. 41, Issue 12, pp. 868-74, (2009) (PubMed).

    Abe, Numakura, Saito, Koide, Oka, Honma, Kishikawa, Hayasaka: "Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype." dans: Journal of human genetics, Vol. 54, Issue 2, pp. 94-7, (2009) (PubMed).

  • Antigène
    NEFL (Neurofilament, Light Polypeptide (NEFL))
    Autre désignation
    NEFL (NEFL Produits)
    Synonymes
    anticorps NEFL, anticorps nefl, anticorps zgc:136626, anticorps AI847934, anticorps CMT2E, anticorps NF-L, anticorps NF68, anticorps Nfl, anticorps CMT1F, anticorps NFL, anticorps XNF-L, anticorps neurofilament light, anticorps neurofilament, light polypeptide, anticorps neurofilament, light polypeptide b, anticorps neurofilament, light L homeolog, anticorps NEFL, anticorps neflb, anticorps Nefl, anticorps nefl.L
    Sujet

    Description: Neurofilaments are type IV intermediate filament heteropolymers composed of light, medium, and heavy chains. Neurofilaments comprise the axoskeleton and they functionally maintain the neuronal caliber. They may also play a role in intracellular transport to axons and dendrites. This gene encodes the light chain neurofilament protein. Mutations in this gene cause Charcot-Marie-Tooth disease types 1F (CMT1F) and 2E (CMT2E), disorders of the peripheral nervous system that are characterized by distinct neuropathies. A pseudogene has been identified on chromosome Y.

    Aliases: NFL, NF-L, NF68, CMT1F, CMT2E

    Poids moléculaire
    62kDa
    ID gène
    4747
    HGNC
    4747
    UniProt
    P07196
Vous êtes ici:
Support technique